ANAB AnaptysBio, Inc. - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 五月 12, 2026
$48.53
· % 处于52周区间
· 高于低点
· 至高点
$29.4852周低点
$73.3052周高点
市值 (MRQ)
$1.41B
P/E (TTM)
-47.6
EPS (TTM)
$-1.02
收入 (TTM)
$232M
ANAB 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$48.53
市值 (MRQ)
$1.41B
P/E (TTM)
-47.6
EPS (TTM)
$-1.02
收入 (TTM)
$232M
ROE (TTM)
-114.6%
52周区间
$29–$73
ANAB 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
股票拆分
| 除息日 | 拆股 | 类型 |
|---|---|---|
| 2026年4月20日 | 3-for-2 | 正向 |
10年表现 收入、净利润、利润率和每股收益趋势
收入$235M2016-12-31 → 2025-12-31
EPS$-0.462016-12-31 → 2025-12-31
自由现金流·2018-12-31 → 2024-12-31
净利率-11.5%2018-12-31 → 2024-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | ANAB | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -47.65年均值 ≈-27.0 | ≈-27.0 | · | · | |
| P/S (TTM) | 6.15年均值 ≈34.7 | ≈34.7 | 11.4 | 低估 | |
| 市净率 (MRQ) | 110.55年均值 ≈4.6 | ≈4.6 | 3.1 | 估值过高 | |
| 股价/自由现金流 (TTM) | 319.55年均值 ≈-10.0 | ≈-10.0 | · | · | |
| 市现率 (TTM) | 314.65年均值 ≈-10.2 | ≈-10.2 | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 36.55年均值 ≈10.9 | ≈10.9 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | ANAB | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | 17.6%5年均值 ≈-573.4% | ≈-573.4% | -135.5% | 持平 | |
| 息税折旧摊销前利润率 (TTM) | 17.8%5年均值 ≈-570.4% | ≈-570.4% | -135.0% | 持平 | |
| 税前利润率 (TTM) | -11.5%5年均值 ≈-613.8% | ≈-613.8% | -206.8% | 持平 | |
| 净利润率 (TTM) | -11.5%5年均值 ≈-613.9% | ≈-613.9% | -206.9% | 持平 | |
| ROA (TTM) | -7.1%5年均值 ≈-23.3% | ≈-23.3% | -37.9% | 顶尖 | |
| ROE (TTM) | -114.6%5年均值 ≈-101.8% | ≈-101.8% | -51.2% | 顶尖 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | ANAB | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 7.65年均值 ≈18.0 | ≈18.0 | 11.1 | 低流动性 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | ANAB | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 157.0%5年均值 ≈111.3% | ≈111.3% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 183.6%5年均值 ≈52.6% | ≈52.6% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 25.6% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | ANAB | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$2.3M | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
12.1%
下次报告
十一月 02, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 九月 11, 2026 | $0.07 | $0.00 | — |
| 2026年3月31日 | 五月 7, 2026 | $-1.84 | $-0.62 | -198.7% |
| 2025年12月31日 | $1.58 | $0.96 | 65.0% | |
| 2025年9月30日 | $0.52 | $-1.47 | 135.4% | |
| 2025年6月30日 | $-1.34 | $-1.57 | 14.8% | |
| 2025年3月31日 | $-1.28 | $-1.28 | -0.12% | |
| 2024年12月31日 | $-0.72 | $-1.65 | 56.4% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $235M | $91M | $17M | $10M | $63M | $75M | $8M | $5M | $10M | $17M | |
| R&D Expense | · | · | · | $89M | $98M | $80M | $99M | $56M | $29M | $15M | |
| SG&A Expense | $51M | $42M | $42M | $37M | $21M | $19M | $16M | $16M | $9M | $4M | |
| Operating Expenses | $187M | $206M | $182M | $125M | $120M | $99M | $115M | $72M | $39M | $20M | |
| Operating Income | $48M | $-115M | $-164M | $-115M | $-57M | $-24M | $-107M | $-67M | $-29M | $-3M | |
| Interest Expense | · | · | · | · | $0 | $0 | $1M | $2M | $2M | $458.0K | |
| Interest Income | · | · | · | · | · | · | · | · | $2M | $127.0K | |
| Other Non-op | $5M | $14.0K | $-2.0K | $12.0K | $37.0K | $-11.0K | $1.0K | $-159.0K | $229.0K | $-147.0K | |
| Pretax Income | $-13M | $-145M | $-164M | $-129M | $-58M | $-20M | $-97M | $-62M | $-30M | $-4M | |
| Income Tax | $164.0K | $3.0K | $-4.0K | $24.0K | $0 | $0 | $-152.0K | $-192.0K | $0 | $0 | |
| Net Income | $-13M | $-145M | $-164M | $-129M | $-58M | $-20M | $-97M | $-62M | $-30M | $-4M | |
| EPS (Basic) | $-0.46 | $-5.12 | $-6.08 | $-4.57 | $-2.11 | $-0.73 | $-3.60 | $-2.50 | $-1.52 | $-1.62 | |
| EPS (Diluted) | $-0.46 | $-5.12 | $-6.08 | $-4.57 | $-2.11 | $-0.73 | $-3.60 | $-2.50 | $-1.52 | $-1.62 | |
| Shares (Basic) | 28,758,000 | 28,382,000 | 26,924,000 | 28,165,000 | 27,431,000 | 27,302,000 | 27,059,000 | · | · | · | |
| Shares (Diluted) | 28,758,000 | 28,382,000 | 26,924,000 | 28,165,000 | 27,431,000 | 27,302,000 | 27,059,000 | · | · | · | |
| EBITDA | · | $-114M | $-164M | $-114M | $-56M | $-23M | $-107M | $-66M | · | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $238M | $123M | $36M | $71M | $496M | $250M | $171M | $114M | $81M | $51M | |
| Receivables | $34M | $41M | $7M | $1M | $876.0K | $0 | $0 | $0 | $0 | $1M | |
| Prepaid Expense | $5M | $6M | $9M | $5M | $5M | $3M | $4M | $7M | $3M | $2M | |
| Current Assets | $350M | $432M | $407M | $447M | $554M | $397M | $378M | $434M | $253M | $58M | |
| PP&E (Net) | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $665.0K | $471.0K | |
| PP&E (Gross) | $9M | $8M | $8M | $8M | $7M | $7M | $6M | $6M | $5M | $4M | |
| Accum. Depreciation | $7M | $7M | $6M | $6M | $5M | $5M | $5M | $4M | $4M | $4M | |
| Other Non-current Assets | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | $258.0K | $1M | $148.0K | $46.0K | · | |
| Total Assets | $364M | $484M | $452M | $610M | $643M | $417M | $435M | $509M | $329M | $62M | |
| Accounts Payable | $4M | $4M | $5M | $3M | $2M | $4M | $16M | $5M | $2M | $2M | |
| Accrued Liabilities | $33M | $40M | $31M | $22M | $13M | $15M | $11M | $9M | $5M | $3M | |
| Short-term Debt | · | · | · | · | · | $0 | $1M | $8M | $7M | $0 | |
| Current Liabilities | $39M | $45M | $37M | $26M | $16M | $20M | $30M | $22M | $14M | $6M | |
| Capital Leases | $12M | $14M | $16M | $18M | $19M | $0 | $654.0K | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | $0 | $654.0K | $796.0K | · | · | |
| Total Debt | · | · | · | · | · | $0 | $1M | $8M | · | · | |
| Common Stock | $28.0K | $30.0K | $27.0K | $29.0K | $28.0K | $27.0K | $27.0K | $27.0K | $24.0K | $3.0K | |
| Paid-in Capital | $810M | $830M | $703M | $718M | $679M | $661M | $649M | $633M | $393M | $17M | |
| Retained Earnings | $-773M | $-759M | $-614M | $-450M | $-322M | $-264M | $-244M | $-147M | $-85M | $-55M | |
| AOCI | $-24.0K | $305.0K | $-797.0K | $-5M | $-422.0K | $-4.0K | $338.0K | $-223.0K | $-426.0K | $0 | |
| Stockholders' Equity | $37M | $71M | $88M | $262M | $356M | $397M | $405M | $486M | $308M | $-38M | |
| Liabilities + Equity | $364M | $484M | $452M | $610M | $643M | $417M | $435M | $509M | $329M | $62M | |
| Shares Outstanding | 28,019,000 | 30,473,000 | 26,597,000 | 28,513,000 | 27,647,000 | 27,356,000 | 27,255,000 | 26,922,000 | 23,791,000 | 2,651,000 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $559.0K | $606.0K | $652.0K | $675.0K | $619.0K | $559.0K | $514.0K | $315.0K | $183.0K | $233.0K | |
| Stock-based Comp | $36M | $34M | $33M | $27M | $15M | · | · | · | $4M | $1M | |
| Other Non-cash | · | $-25M | $9M | $54M | $11M | $5M | $27M | $13M | · | · | |
| Operating Cash Flow | $20M | $-135M | $-121M | $-74M | $-46M | $-14M | $-70M | $-49M | $-19M | $-9M | |
| CapEx | $87.0K | $358.0K | $807.0K | $358.0K | $1M | $569.0K | $805.0K | $1M | $290.0K | $50.0K | |
| Investing Cash Flow | $228M | $95M | $145M | $-395M | $39M | $94M | $131M | $-142M | $-243M | $-50.0K | |
| Stock Issued | $14M | $6M | $2M | $12M | $3M | $496.0K | $3M | $227M | $293M | $0 | |
| Stock Repurchased | $69M | $456.0K | $50M | $0 | $0 | · | · | $0 | $0 | $1.0K | |
| Net Stock Activity | · | $6M | $-48M | $12M | $3M | $0 | $0 | $227M | · | · | |
| Financing Cash Flow | $-133M | $127M | $-59M | $44M | $252M | $-879.0K | $-4M | $223M | $292M | $9M | |
| Net Change in Cash | $115M | $87M | $-35M | $-424M | $245M | $79M | $57M | $32M | · | · | |
| Free Cash Flow | · | $-136M | $-122M | $-74M | $-47M | $-15M | $-70M | $-50M | · | · | |
| Levered FCF | · | · | · | · | $-47M | $-15M | $-71M | $-51M | · | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -125.9% | -958.3% | -1119.4% | -89.9% | -31.8% | -1342.9% | -1334.4% | · | · | |
| Net Margin | · | -159.1% | -953.7% | -1251.3% | -91.5% | -26.6% | -1216.7% | -1233.1% | · | · | |
| Pretax Margin | · | -159.1% | -953.7% | -1251.1% | -91.5% | -26.6% | -1218.6% | -1237.0% | · | · | |
| EBITDA Margin | · | -125.3% | -954.5% | -1112.9% | -88.9% | -31.1% | -1336.5% | -1328.1% | · | · | |
| ROA | · | -31.0% | -30.8% | -20.5% | -10.9% | -4.7% | -20.6% | -14.7% | · | · | |
| ROE | · | -187.1% | -157.0% | -47.7% | -15.6% | -5.3% | -23.6% | -12.5% | · | · | |
| ROIC | · | -162.2% | -186.6% | -43.9% | -15.9% | -6.0% | -26.4% | -13.5% | · | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 9.5 | 10.9 | 17.2 | 34.4 | 20.0 | 12.8 | 19.9 | · | · | |
| Quick Ratio | · | 3.6 | 1.1 | 2.8 | 30.8 | 12.6 | 5.8 | 5.2 | · | · | |
| Debt / Equity | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | · | |
| Interest Coverage | · | · | · | · | · | · | -103.2 | -40.4 | · | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | 0.0 | 0.0 | 0.1 | 0.2 | 0.0 | 0.0 | · | · | |
| Receivables Turnover | · | 3.8 | 4.1 | 9.0 | 144.2 | · | · | · | · | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $2.33 | $3.31 | $9.19 | $12.89 | $14.50 | $14.86 | $18.07 | · | · | |
| Revenue / Share | · | $3.22 | $0.64 | $0.37 | $2.30 | · | · | · | · | · | |
| Cash Flow / Share | · | $-4.77 | $-4.49 | $-2.61 | $-1.67 | · | · | · | · | · | |
| Cash / Share | · | $4.04 | $1.35 | $2.50 | $17.93 | $9.16 | $6.27 | $4.22 | · | · | |
| EPS (TTM) | $-0.46 | $-5.12 | $-6.08 | $-4.57 | $-2.11 | $-0.73 | $-3.60 | $-2.50 | $-1.52 | $-1.62 |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 157.0% | 432.0% | 66.8% | -83.7% | -15.8% | · | · | · | · | · | |
| Revenue CAGR 3Y | 183.6% | 13.1% | -38.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 25.6% | · | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $235M | $91M | $17M | $10M | $63M | $75M | $8M | $5M | $10M | $17M | |
| Net Income TTM | $-13M | $-145M | $-164M | $-129M | $-58M | $-20M | $-97M | $-62M | $-30M | $-4M | |
| Market Cap | · | $403M | $570M | $884M | $961M | $588M | $443M | $1.72B | · | · | |
| Enterprise Value | · | · | · | · | · | $338M | $273M | $1.61B | · | · | |
| P/E | -105.4 | -2.6 | -3.5 | -6.8 | -16.5 | -29.5 | -4.5 | -25.5 | -66.3 | · | |
| P/S | · | 4.4 | 33.2 | 85.9 | 15.2 | 7.8 | 55.4 | 343.5 | · | · | |
| P/B | · | 5.7 | 6.5 | 3.4 | 2.7 | 1.5 | 1.1 | 3.5 | · | · | |
| P / Tangible Book | 36.5 | 5.7 | 6.5 | 3.4 | 2.7 | 1.5 | · | · | · | · | |
| P / Cash Flow | · | -3.0 | -4.7 | -12.0 | -20.9 | -41.5 | -6.4 | -35.4 | · | · | |
| P / FCF | · | -3.0 | -4.7 | -11.9 | -20.3 | -39.9 | -6.3 | -34.6 | · | · | |
| EV / EBITDA | · | · | · | · | · | -14.5 | -2.6 | -24.3 | · | · | |
| EV / FCF | · | · | · | · | · | -22.9 | -3.9 | -32.5 | · | · | |
| EV / Revenue | · | · | · | · | · | 4.5 | 34.2 | 322.3 | · | · | |
| Earnings Yield | -0.95% | -38.7% | -28.4% | -14.8% | -6.1% | -3.4% | -22.1% | -3.9% | -1.5% | · |
损益表
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $26M | $108M | $76M | $22M | $28M | $43M | $30M | $11M | $7M | $9M | $3M | $3M | $1M | $1M | $1M | $970.0K | |
| R&D Expense | · | · | $31M | $38M | $41M | · | $42M | $42M | $37M | · | $31M | $33M | $35M | $22M | $21M | $23M | |
| SG&A Expense | $26M | $16M | $10M | $11M | $14M | $10M | $11M | $9M | $12M | $10M | $10M | $11M | $11M | $9M | $8M | $10M | |
| Operating Expenses | $60M | $41M | $42M | $48M | $55M | $53M | $53M | $51M | $49M | $51M | $41M | $44M | $46M | $31M | $29M | $33M | |
| Operating Income | $-35M | $67M | $35M | $-26M | $-28M | $-10M | $-23M | $-40M | $-42M | $-42M | $-38M | $-40M | $-44M | $-30M | $-28M | $-32M | |
| Other Non-op | $-1.0K | $-3.0K | $0 | $4M | $2M | $21.0K | $-5.0K | $0 | $-2.0K | $-2.0K | $1.0K | $3.0K | $-4.0K | $4.0K | $6.0K | $6.0K | |
| Pretax Income | $-53M | $50M | $15M | $-39M | $-39M | $-22M | $-33M | $-47M | $-44M | $-42M | $-37M | $-40M | · | · | · | · | |
| Income Tax | $40.0K | $81.0K | $0 | $39.0K | $44.0K | $-6.0K | $0 | $9.0K | $0 | $-4.0K | $0 | · | · | · | · | · | |
| Net Income | $-53M | $50M | $15M | $-39M | $-39M | $-22M | $-33M | $-47M | $-44M | $-42M | $-37M | $-40M | $-44M | $-34M | $-33M | $-36M | |
| EPS (Basic) | $-1.84 | $1.62 | $0.54 | $-1.34 | $-1.28 | $-0.63 | $-1.14 | $-1.71 | $-1.64 | $-1.59 | $-1.41 | $-1.50 | $-1.58 | $-1.18 | $-1.15 | $-1.31 | |
| EPS (Diluted) | $-1.84 | $1.64 | $0.52 | $-1.34 | $-1.28 | $-0.63 | $-1.14 | $-1.71 | $-1.64 | $-1.59 | $-1.41 | $-1.50 | $-1.58 | $-1.18 | $-1.15 | $-1.31 | |
| Shares (Basic) | 28,691,000 | · | 27,833,000 | 28,810,000 | 30,644,000 | · | 28,893,000 | 27,356,000 | 26,801,000 | · | 26,546,000 | 26,629,000 | 27,953,000 | 28,289,000 | 28,204,000 | 27,713,000 | |
| Shares (Diluted) | 28,691,000 | · | 29,018,000 | 28,810,000 | 30,644,000 | · | 28,893,000 | 27,356,000 | 26,801,000 | · | 26,546,000 | 26,629,000 | 27,953,000 | 28,289,000 | 28,204,000 | 27,713,000 | |
| EBITDA | $-35M | · | $35M | $-26M | $-27M | · | $-23M | $-40M | $-42M | · | $-38M | $-40M | $-44M | $-30M | $-28M | $-32M |
资产负债表
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $248M | $238M | $110M | $44M | $99M | $123M | $192M | $72M | $54M | · | $26M | $35M | $95M | $59M | $72M | $166M | |
| Receivables | $26M | $34M | $76M | $21M | $18M | $41M | $12M | $9M | $7M | · | $3M | $3M | $2M | $1M | $1M | $921.0K | |
| Prepaid Expense | $4M | $5M | $6M | $5M | $5M | $6M | $6M | $8M | $11M | · | $12M | $6M | $4M | $6M | $10M | $6M | |
| Current Assets | $316M | $350M | $331M | $292M | $363M | $432M | $449M | $367M | $372M | · | $428M | $439M | $437M | $450M | $453M | $512M | |
| PP&E (Net) | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $8M | $8M | · | $8M | $8M | $8M | $7M | $7M | $7M | |
| Accum. Depreciation | $7M | $7M | $7M | $7M | $7M | $7M | $6M | $7M | $6M | · | $6M | $6M | $6M | $5M | $5M | $5M | |
| Other Non-current Assets | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | · | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | $256.0K | |
| Total Assets | $330M | $364M | $353M | $335M | $422M | $484M | $493M | $427M | $406M | · | $487M | $517M | $552M | $619M | $604M | $625M | |
| Accounts Payable | $8M | $4M | $3M | $3M | $6M | $4M | $4M | $5M | $5M | · | $7M | $5M | $3M | $3M | $2M | $2M | |
| Accrued Liabilities | $32M | $33M | $33M | $30M | $36M | $40M | $38M | $34M | $26M | · | $31M | $35M | $31M | $16M | $17M | $16M | |
| Current Liabilities | $42M | $39M | $38M | $36M | $44M | $45M | $44M | $40M | $32M | · | $39M | $42M | $36M | $21M | $20M | $20M | |
| Capital Leases | $11M | $12M | $13M | $13M | $14M | $14M | $15M | $15M | $16M | · | $16M | $17M | $17M | $18M | $19M | $19M | |
| Common Stock | $29.0K | $28.0K | $28.0K | $28.0K | $30.0K | $30.0K | $30.0K | $27.0K | $27.0K | · | $27.0K | $27.0K | $27.0K | $28.0K | $28.0K | $28.0K | |
| Paid-in Capital | $838M | $810M | $793M | $793M | $832M | $830M | $821M | $715M | $706M | · | $695M | $687M | $689M | $708M | $699M | $691M | |
| Retained Earnings | $-825M | $-773M | $-822M | $-837M | $-799M | $-759M | $-738M | $-705M | $-658M | · | $-572M | $-535M | $-495M | $-424M | $-391M | $-358M | |
| AOCI | $-146.0K | $-24.0K | $47.0K | $-6.0K | $161.0K | $305.0K | $759.0K | $-415.0K | $-624.0K | · | $-2M | $-4M | $-3M | $-6M | $-4M | $-2M | |
| Stockholders' Equity | $13M | $37M | $-29M | $-45M | $34M | $71M | $84M | $10M | $48M | $88M | $120M | $148M | $191M | $278M | $304M | $331M | |
| Liabilities + Equity | $330M | $364M | $353M | $335M | $422M | $484M | $493M | $427M | $406M | · | $487M | $517M | $552M | $619M | $604M | $625M | |
| Shares Outstanding | 29,031,000 | 28,019,000 | 27,575,000 | 27,973,000 | 30,388,000 | 30,473,000 | 30,429,000 | 27,434,000 | 27,317,000 | 26,597,000 | 26,575,000 | 26,531,000 | 27,018,000 | 28,354,000 | 28,231,000 | 28,178,000 |
现金流
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $130.0K | $131.0K | $140.0K | $142.0K | $146.0K | $145.0K | $144.0K | $154.0K | $163.0K | $165.0K | $158.0K | $163.0K | $166.0K | $166.0K | $163.0K | $162.0K | |
| Stock-based Comp | $14M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $10M | $8M | $8M | $8M | $9M | $6M | $7M | $8M | |
| Other Non-cash | $13M | · | · | · | $19M | · | · | · | $-4M | · | · | · | $11M | · | · | $7M | |
| Operating Cash Flow | $-26M | $98M | $-27M | $-40M | $-11M | $-67M | $-10M | $-21M | $-37M | $-34M | $-36M | $-25M | $-25M | $-18M | $-24M | $-21M | |
| CapEx | $17.0K | $1.0K | $12.0K | $39.0K | $35.0K | $263.0K | $35.0K | $33.0K | $27.0K | $280.0K | $162.0K | $190.0K | $175.0K | $50.0K | $78.0K | $55.0K | |
| Investing Cash Flow | $35M | $74M | $103M | $36M | $15M | $-29M | $59M | $-2M | $69M | $49M | $31M | $-20M | $85M | $-32M | $-71M | $-313M | |
| Stock Issued | $14M | $12M | $336.0K | $1M | $290.0K | $555.0K | $4M | $979.0K | $811.0K | $264.0K | $160.0K | $783.0K | $1M | $3M | $865.0K | $5M | |
| Stock Repurchased | $0 | $3M | $10M | $51M | $4M | $456.0K | $0 | $0 | $0 | $0 | $0 | $12M | $38M | $0 | $0 | $0 | |
| Net Stock Activity | $14M | · | · | · | $-4M | · | · | · | $811.0K | · | · | · | $-36M | · | · | $5M | |
| Financing Cash Flow | $1M | $-43M | $-10M | $-50M | $-29M | $28M | $71M | $42M | $-14M | $-5M | $-3M | $-13M | $-38M | $37M | $432.0K | $5M | |
| Net Change in Cash | $10M | $128M | $66M | $-54M | $-24M | $-69M | $120M | $18M | $18M | $10M | $-9M | $-59M | $23M | $-13M | $-95M | $-329M | |
| Free Cash Flow | $-26M | · | · | · | $-11M | · | · | · | $-37M | · | · | · | $-25M | · | · | $-21M |
盈利能力
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -135.5% | · | 45.5% | -117.5% | -99.2% | · | -75.8% | -367.5% | -587.8% | · | -1137.2% | -1160.2% | -3231.5% | -2291.8% | -2286.1% | -3273.1% | |
| Net Margin | -206.9% | · | 19.8% | -173.5% | -141.6% | · | -109.4% | -425.3% | -612.0% | · | -1124.4% | -1151.6% | -3220.9% | -2591.0% | -2677.1% | -3737.6% | |
| Pretax Margin | -206.8% | · | 19.8% | -173.3% | -141.5% | · | -109.4% | -425.2% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -135.0% | · | 45.5% | -117.5% | -98.6% | · | -75.8% | -367.5% | -585.6% | · | -1137.2% | -1160.2% | -3219.4% | -2291.8% | -2286.1% | -3256.4% | |
| ROA | -14.1% | · | 3.6% | -10.1% | -9.5% | · | -6.7% | -9.9% | -9.2% | · | -6.8% | -7.1% | -7.5% | -6.4% | -6.3% | -7.1% | |
| ROE | -226.1% | · | 55.0% | 221.7% | -96.2% | · | -32.1% | -58.9% | -36.8% | · | -18.8% | -17.6% | -17.0% | -10.1% | -9.4% | -10.2% | |
| ROIC | -271.9% | · | -118.0% | 58.6% | -81.0% | · | -27.0% | -408.2% | · | · | · | · | · | · | · | · |
流动性与偿付能力
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.6 | · | 8.7 | 8.2 | 8.2 | · | 10.2 | 9.1 | 11.5 | · | 10.9 | 10.5 | 12.2 | 21.4 | 22.8 | 25.9 | |
| Quick Ratio | 6.6 | · | 4.9 | 1.8 | 2.6 | · | 4.6 | 2.0 | 1.9 | · | 0.8 | 0.9 | 2.7 | 2.8 | 3.7 | 8.5 |
效率
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 1.2 | · | 1.7 | 1.5 | 2.2 | · | 3.9 | 1.8 | 1.7 | · | 1.5 | 1.6 | 1.1 | 1.3 | 1.5 | 0.9 |
每股
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.44 | · | $-1.07 | $-1.60 | $1.12 | · | $2.77 | $0.36 | $1.75 | · | $4.53 | $5.60 | $7.07 | $9.79 | $10.78 | $11.74 | |
| Revenue / Share | $0.89 | · | $2.63 | $0.77 | $0.91 | · | $1.04 | $0.40 | $0.27 | · | $0.12 | $0.13 | $0.05 | $0.05 | $0.04 | $0.04 | |
| Cash Flow / Share | $-0.90 | · | · | · | $-0.35 | · | · | · | $-1.39 | · | · | · | $-0.88 | · | · | $-0.76 | |
| Cash / Share | $8.56 | · | $3.98 | $1.58 | $3.25 | · | $6.30 | $2.62 | $1.97 | · | $0.99 | $1.33 | $3.50 | $2.06 | $2.54 | $5.91 | |
| EPS (TTM) | $-1.02 | · | $-2.73 | $-4.39 | $-4.76 | · | $-6.08 | $-6.35 | $-6.14 | · | $-5.42 | $-5.19 | $-4.84 | $-4.83 | $-3.89 | $-2.76 |
估值 (TTM)
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $232M | · | $169M | $123M | $112M | · | $57M | $30M | $23M | · | $15M | $13M | $11M | $4M | $24M | $53M | |
| Net Income TTM | $-27M | · | $-85M | $-133M | $-141M | · | $-166M | $-170M | $-163M | · | $-148M | $-144M | $-137M | $-135M | $-108M | $-76M | |
| Market Cap | $1.61B | · | $844M | $621M | $565M | · | $1.02B | $687M | $615M | · | $477M | $540M | $588M | $723M | $573M | $697M | |
| P/E | -54.4 | · | -11.2 | -5.1 | -3.9 | · | -5.5 | -3.9 | -3.7 | · | -3.3 | -3.9 | -4.5 | -5.3 | -5.2 | -9.0 | |
| P/S | 6.9 | · | 5.0 | 5.0 | 5.0 | · | 17.8 | 22.6 | 26.8 | · | 31.9 | 41.7 | 55.0 | 161.1 | 23.8 | 13.2 | |
| P/B | 126.3 | · | -28.7 | -13.9 | 16.6 | · | 12.1 | 69.6 | 12.9 | · | 4.0 | 3.6 | 3.1 | 2.6 | 1.9 | 2.1 | |
| P / Tangible Book | 126.3 | · | · | · | 16.6 | · | 12.1 | 69.6 | 12.9 | · | 4.0 | 3.6 | 3.1 | 2.6 | 1.9 | 2.1 | |
| P / Cash Flow | -62.1 | · | · | · | -52.8 | · | · | · | -16.5 | · | · | · | -23.9 | · | · | -33.2 | |
| Earnings Yield | -1.8% | · | -8.9% | -19.8% | -25.6% | · | -18.1% | -25.3% | -27.3% | · | -30.2% | -25.5% | -22.2% | -18.9% | -19.2% | -11.2% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $235M | $91M | $17M | $10M | $63M |
| 营业利润率 % | · | -125.9% | -958.3% | -1119.4% | -89.9% |
| 净收入 | $-13M | $-145M | $-164M | $-129M | $-58M |
| 稀释后每股收益 (EPS) | $-0.46 | $-5.12 | $-6.08 | $-4.57 | $-2.11 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | · | 9.5 | 10.9 | 17.2 | 34.4 |
| 速动比率 | · | 3.6 | 1.1 | 2.8 | 30.8 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | · | $-136M | $-122M | $-74M | $-47M |
机构持有人 (13F) 226 家申报者 · $2.1B 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
226
持有价值
$2.1B
新仓位
47
已退出持仓
34
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 47 (-6 与上一季度对比) | 34 (+15 与上一季度对比) | 74 (+18 与上一季度对比) | 63 (-8 与上一季度对比) | +2.1M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| EcoR1 Capital, LLC | $531906345 | 7880094 | 24.81% | 股份 |
| BlackRock, Inc. | $124473310 | 1844049 | 5.81% | 股份 |
| TANG CAPITAL MANAGEMENT LLC | $89834333 | 1330879 | 4.19% | 股份 |
| STATE STREET CORP | $86818095 | 1286194 | 4.05% | 股份 |
| VANGUARD GROUP INC | $74854914 | 1544037 | 3.49% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $61170728 | 906233 | 2.85% | 股份 |
| Affinity Asset Advisors, LLC | $55762358 | 826109 | 2.60% | 股份 |
| Sanofi | $55479398 | 821917 | 2.59% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $54493830 | 807316 | 2.54% | 股份 |
| Woodline Partners LP | $48398445 | 717014 | 2.26% | 股份 |
| 683 Capital Management, LLC | $44550001 | 660000 | 2.08% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $43064353 | 637873 | 2.01% | 股份 |
| Palo Alto Investors LP | $40735508 | 603489 | 1.90% | 股份 |
| GOLDMAN SACHS GROUP INC | $39424725 | 584070 | 1.84% | 股份 |
| First Light Asset Management, LLC | $39285270 | 582004 | 1.83% | 股份 |
| D. E. Shaw & Co., Inc. | $36427456 | 539666 | 1.70% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $35630415 | 527858 | 1.66% | 股份 |
| Apis Capital Advisors, LLC | $33547500 | 497000 | 1.56% | 股份 |
| Sofinnova Investments, Inc. | $33313680 | 493536 | 1.55% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $32983943 | 488651 | 1.54% | 股份 |
| Nuveen, LLC | $28394821 | 420664 | 1.32% | 股份 |
| BANK OF AMERICA CORP /DE/ | $28202310 | 417812 | 1.32% | 股份 |
| CITADEL ADVISORS LLC | $26620178 | 394373 | 1.24% | 股份 |
| FEDERATED HERMES, INC. | $26437523 | 391667 | 1.23% | 股份 |
| Squarepoint Ops LLC | $21900105 | 324446 | 1.02% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $17752163 | 262995 | 0.83% | 股份 |
| FIRST TRUST ADVISORS LP | $17481757 | 258989 | 0.82% | 股份 |
| MORGAN STANLEY | $17353682 | 257091 | 0.81% | 股份 |
| TWO SIGMA ADVISERS, LP | $17292816 | 356700 | 0.81% | 股份 |
| Coppell Advisory Solutions LLC | $16575695 | 3638 | 0.77% | 股份 |
| FMR LLC | $16234486 | 240511 | 0.76% | 股份 |
| Qube Research & Technologies Ltd | $15442448 | 228777 | 0.72% | 股份 |
| HSBC HOLDINGS PLC | $14928261 | 216949 | 0.70% | 股份 |
| Empowered Funds, LLC | $13905675 | 206010 | 0.65% | 股份 |
| NORTHERN TRUST CORP | $13686773 | 202767 | 0.64% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $13655588 | 202305 | 0.64% | 股份 |
| Invesco Ltd. | $13638781 | 202056 | 0.64% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $12517471 | 185444 | 0.58% | 股份 |
| Greenhaven Road Investment Management, L.P. | $11546483 | 171059 | 0.54% | 股份 |
| VICTORY CAPITAL MANAGEMENT INC | $11422823 | 169227 | 0.53% | 股份 |
| MACKENZIE FINANCIAL CORP | $10191083 | 150979 | 0.48% | 股份 |
| UBS Group AG | $9911161 | 146832 | 0.46% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $9903870 | 146724 | 0.46% | 股份 |
| Connor, Clark & Lunn Investment Management Ltd. | $9519256 | 141026 | 0.44% | 股份 |
| Ensign Peak Advisors, Inc | $7228980 | 107096 | 0.34% | 股份 |
| FRANKLIN RESOURCES INC | $7219058 | 106949 | 0.34% | 股份 |
| CITIGROUP INC | $6690195 | 99114 | 0.31% | 股份 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $6327000 | 93732 | 0.30% | 股份 |
| PRUDENTIAL FINANCIAL INC | $5800410 | 85932 | 0.27% | 股份 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $5666085 | 83942 | 0.26% | 股份 |
激进投资者及 5%+ 股东 2 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC, Oleg Nodelman, EcoR1 Capital Fund Qualified, L.P. ×5 申报 | 2024年8月16日 | · | 初始申报 | 董事会活动 | SEC |
| Frazier Healthcare V, L.P., FHM V, L.P., FHM V, L.L.C., Frazier Healthcare VII, L.P., Frazier Healthcare VII-A, L.P., FHM VII, L.P., FHM VII, L.L.C., James N. Topper, Patrick J. Heron, Alan Frazier, Nader Naini, Nathan Every, Brian Morfitt ×5 申报 | 2020年11月18日 | · | 初始申报 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 25 位内幕人士 · 7 位高管 · 14 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Daniel Faga | President, CEO | 2026年3月12日 A | 495965 | 0 | 13 | $-2805094 |
| Hamza Suria | President, CEO | 2022年2月10日 A | 68600 | 0 | 0 | $0 |
| Christopher M. Murphy | Chief Financial Officer | 2026年5月11日 A | · | 0 | 0 | $0 |
| Dominic Piscitelli | Chief Financial Officer | 2019年2月8日 A | 0 | 0 | 0 | $0 |
| Lizzul Paul F. | Chief Medical Officer | 2026年3月12日 A | 42088 | 0 | 4 | $-521527 |
| Marco Londei | Chief Medical Officer | 2019年12月6日 A | 68579 | 0 | 0 | $0 |
| Matthew Moyle | Chief Scientific Officer | 2017年2月24日 A | · | 0 | 0 | $0 |
| Hollings Renton | 董事 | 2026年10月1日 M | 10995 | 0 | 1 | $-249350 |
| John A Orwin | 董事 | 2026年9月15日 M | 17995 | 0 | 0 | $0 |
| John P. Schmid | 董事 | 2026年6月15日 M | 37652 | 0 | 3 | $-1158467 |
| Owen Hughes | 董事 | 2026年5月11日 A | · | 0 | 0 | $0 |
| Susannah Gray | 董事 | 2026年4月27日 A | · | 0 | 0 | $0 |
| Magda Marquet | 董事 | 2026年1月15日 M | 9930 | 0 | 2 | $-530569 |
| Anthony J. Ware | 董事 | 2026年1月6日 A | 9630 | 0 | 1 | $-193362 |
| Rita Jain | 董事 | 2026年1月6日 A | 11864 | 0 | 0 | $0 |
| Dennis M Fenton | 董事 | 2026年1月6日 A | 4965 | 0 | 0 | $0 |
| Nicholas Lydon | 董事 | 2019年2月8日 A | 271106 | 0 | 0 | $0 |
| James A Schoeneck | 董事 | 2018年2月2日 A | · | 0 | 0 | $0 |
| Carol Giltner Gallagher | 董事 | 2018年2月2日 A | 64296 | 0 | 0 | $0 |
| EcoR1 Capital, LLC | 10% 所有者 | 2024年8月14日 P | 7794996 | 0 | 0 | $0 |
| Novo Holdings A/S | 10% 所有者 | 2017年8月21日 S | 1936604 | 0 | 0 | $0 |
| Eric J Loumeau | · | 2026年2月11日 M | 12835 | 0 | 12 | $-2744508 |
| Dennis Mulroy | · | 2026年1月7日 M | 21852 | 0 | 6 | $-1549401 |
| Laura Hamill | · | 2023年1月6日 A | · | 0 | 0 | $0 |
| James N. Topper | · | 2023年1月6日 A | 80812 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 33 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| PBE · Invesco Exchange-Traded Fund Trust | 2.36% | 201034 SH | 2026年10月2日 | 每日 |
| BRNY · EA Series Trust | 1.14% | 123969 NS | 2026年7月31日 | N-PORT |
| BBC · ETFis Series Trust I | 0.64% | 5543 NS | 2026年7月31日 | N-PORT |
| FYC · First Trust Exchange-Traded Alpha... | 0.53% | 130011 NS | 2026年7月31日 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Inde... | 0.45% | 24411 SH | 2026年10月2日 | 每日 |
| LABU · Direxion Shares ETF Trust | 0.29% | 26728 NS | 2026年7月31日 | N-PORT |
| FYX · First Trust Exchange-Traded Alpha... | 0.25% | 64617 NS | 2026年7月31日 | N-PORT |
| ESSC · Strategy Shares | 0.21% | 1384 NS | 2026年7月31日 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.17% | 50791 SH | 2026年8月19日 | 每日 |
| IBB · iShares Trust | 0.11% | 208149 SH | 2026年9月11日 | 每日 |
| FAD · First Trust Exchange-Traded Alpha... | 0.11% | 11777 NS | 2026年7月31日 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.10% | 2103 SH | 2026年10月2日 | 每日 |
| FSMD · FIDELITY COVINGTON TRUST | 0.10% | 44946 NS | 2026年7月31日 | N-PORT |
| PWS · Pacer Funds Trust | 0.08% | 365 NS | 2026年7月31日 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.08% | 21182 SH | 2026年8月19日 | 每日 |
| IWO · iShares Trust | 0.07% | 185565 SH | 2026年9月11日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.04% | 113787 SH | 2026年8月19日 | 每日 |
| IWM · iShares Trust | 0.04% | 510083 SH | 2026年9月11日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.03% | 13704 SH | 2026年10月2日 | 每日 |
| DFAS · Dimensional ETF Trust | 0.02% | 64608 NS | 2026年7月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.02% | 236970 SH | 2026年8月19日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.02% | 47570 SH | 2026年8月19日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 0.01% | 7513 NS | 2026年7月31日 | N-PORT |
| WSML · iShares Trust | 0.01% | 1349 SH | 2026年9月10日 | 每日 |
| ISCG · iShares Trust | 0.01% | 1822 SH | 2026年9月11日 | 每日 |
| IWV · iShares Trust | 0.00% | 7466 SH | 2026年9月10日 | 每日 |
| ITOT · iShares Trust | 0.00% | 29415 SH | 2026年9月11日 | 每日 |
| DFUS · Dimensional ETF Trust | 0.00% | 6052 NS | 2026年7月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 648146 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 1580 SH | 2026年8月19日 | 每日 |
| ISCB · iShares Trust | · | 826 SH | 2026年9月11日 | 每日 |
| ISCV · iShares Trust | · | 2912 SH | 2026年9月11日 | 每日 |
| SMMV · iShares Trust | · | 2453 SH | 2026年9月1日 | 每日 |
ANAB 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 17 位分析师
买入
中位数目标
$79.50
+63.8%
6 35.3%
强烈买入
10 58.8%
买入
1 5.9%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
8 位分析师 · 2026-10-01平均目标 $87.25 +79.8%
← 低于所有目标
当前价格 $48.53
最低$60.00
平均值$87.25
最高$140.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ANAB | · | -105.4 | 157.0% | · | · | · |
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | · |
| SNDX | $1.84B | -6.4 | 627.8% | -165.6% | -257.1% | · |
| XNCR | $1.10B | -12.3 | 13.7% | -73.2% | -14.0% | · |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | · |
| RARE | $2.22B | -3.9 | 20.2% | -85.4% | -1613.2% | · |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | · |
| AVBP | $854M | -4.7 | · | · | -59.7% | · |
| COAG | · | · | · | · | · | · |
| KLRA | · | · | · | · | · | · |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 五月 12, 2026 申报